top of page
Browse by category
Search
BELIEVE study assessing bimagrumab for obesity completes enrolment
The BELIEVE global Phase 2b study - assessing bimagrumab as a single agent and in combination with semaglutide in patients with obesity -...
Browse by tag
bottom of page